Teva- Pharmaceutical Industries Debt to Equity

As of the most recent data, TEVA shows a debt-to-equity ratio of 2.18. That is above the Healthcare sector average of 0.3. Scroll down for historical charts and peer comparison views.

The Healthcare sector average debt-to-equity ratio is about 0.3. Teva- Pharmaceutical Industries is at 2.18, which is higher that average. That is roughly 633.8% above the sector mean. Use the comparison chart on this page to see how TEVA stacks up against individual peers as well.

Investors watch TEVA's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Teva- Pharmaceutical Industries's latest reading is 2.18. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 2.18) with ownership activity and broader fundamentals.

The Healthcare average debt-to-equity ratio is about 0.3, while TEVA is at 2.18. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.